{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:24:53Z","timestamp":1761128693265,"version":"3.33.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1988,7,1]],"date-time":"1988-07-01T00:00:00Z","timestamp":583718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1988,7,1]],"date-time":"1988-07-01T00:00:00Z","timestamp":583718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1988,7]]},"DOI":"10.1136\/ard.47.7.546","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"546-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Class-specific rheumatoid factors, DR antigens, and amyloidosis in patients with rheumatoid arthritis."],"prefix":"10.1016","volume":"47","author":[{"given":"C.P","family":"Maury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M","family":"Teppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Wafin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Wegelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Friman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Koskimies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM198006053022305","article-title":"Amyloid deposits and amyloidosis","volume":"302","author":"G, I.Glenner G.","year":"1980","unstructured":"I Glenner G G. Amyloid deposits and amyloidosis. The,Bfibrilloses. N Engl J Med 1980; 302: 1283-92, 1333-42.","journal-title":"The, Bfibrilloses. N Engl J Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00541358","article-title":"A review of reactive (secondary) amyloidosis and its pathogenesis","volume":"5","author":"J, Maury C.P.","year":"1984","unstructured":"Maury C P J. A review of reactive (secondary) amyloidosis and its pathogenesis. Rheumatol Int 1984; 5: 1-7.","journal-title":"Rheumatol Int"},{"key":"ref_3","first-page":"767","article-title":"A genetic marker for systemic amyloidosis in juvenile arthritis","volume":"ii:","author":"Woo, P.; O'Brien, J.; Robson, M.; M, Ansell B.","year":"1987","unstructured":"Woo P, O'Brien J, Robson M, Ansell B M. A genetic marker for systemic amyloidosis in juvenile arthritis. Lancet 1987; ii: 767-9.","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1399-0039.1977.tb01086.x","article-title":"HLA-B27 in rheumatoid arthritis and amyloidosis","volume":"9","author":"Pasternack, A.; Tiilikainen, A.","year":"1977","unstructured":"Pasternack A, Tiilikainen A. HLA-B27 in rheumatoid arthritis and amyloidosis. Tissue Antigetns 1977; 9: 80-9.","journal-title":"Tissue Antigetns"},{"key":"ref_5","article-title":"HLA antigens in amyloidosis secondary to rheumatoid arthritis","author":"A, Pasternack A.Tiilikainen; S, Koskimies","year":"1980","unstructured":"Pasternack A. Tiilikainen A, Koskimies S. HLA antigens in amyloidosis secondary to rheumatoid arthritis. In: Glenner G G, Costa P P, Freitas F, eds. Atnyloid and amyloidosis. Amsterdam: Excerpta Medica, 1980: 200-4."},{"key":"ref_6","first-page":"205","article-title":"The HLA antigens in patients with amyloidosis secondary to rheumatic diseases","volume-title":"antd amvloidosis","author":"G, Glenner G.","year":"1980","unstructured":"Wafin F, Wegelius 0, Falck H, Koskimies S. The HLA antigens in patients with amyloidosis secondary to rheumatic diseases. In: Glenner G G, Costa P P, Freitas F, eds. Amyloid antd amvloidosis. Amsterdam: Excerpta Medica, 1980: 205-6."},{"issue":"291","key":"ref_7","first-page":"1915","article-title":"Rheumatoid factors and amyloidosis in rheumatoid arthritis","volume":"1985","author":"J, Maury C.P.; A-M, Teppo","unstructured":"Maury C P J, Teppo A-M. Rheumatoid factors and amyloidosis in rheumatoid arthritis. Br Med J 1985: 291: 1915-6.","journal-title":"Br Med J"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.18.1.49","article-title":"Revision of the diagnostic criteria for rheumatoid arthritis. 1958 revision","volume":"18","author":"W, Ropes M.; A, Bennett G.; S, Cobb; A, Jacox R.Jessar R.","year":"1959","unstructured":"Ropes M W, Bennett G A, Cobb S, Jacox R. Jessar R A. Revision of the diagnostic criteria for rheumatoid arthritis. 1958 revision. Ann Rheum Dis 1959; 18: 49-53.","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"ref_9","first-page":"1501","article-title":"Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis","volume":"1981","author":"W, Wernick R.Lospalluto J.J.Fink C.; M, Ziff","unstructured":"Wernick R. Lospalluto J J. Fink C W, Ziff M. Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis. Arthritis Rheum 1981: 24: 1501-11.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"ref_10","first-page":"220","article-title":"A simple microcytotoxicity test","volume":"1969","author":"Amos, D.; Bashir, H.; Boyle, W.; McQueen, M.; Tiilikainen, A.","unstructured":"Amos D, Bashir H, Boyle W, McQueen M, Tiilikainen A. A simple microcytotoxicity test. Transplatntation 1969; 7: 220-3.","journal-title":"Transplatntation"},{"key":"ref_11","first-page":"18","article-title":"HLA and disease associations","author":"I, Tiwari J.L.Terasaki P.","year":"1985","unstructured":"Tiwari J L. Terasaki P I. HLA and disease associations. New York: Springer, 1985: 18-27."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00007890-198211000-00006","article-title":"Is uremia immunosuppressive in renal transplantation?","volume":"34","author":"Hayry, P.; von Willebrand, E.; Taskinen, E.; Hockerstedt, K.; Ahonen, J.; Eklund, B.","year":"1982","unstructured":"Hayry P, von Willebrand E, Taskinen E, Hockerstedt K, Ahonen J, Eklund B. Is uremia immunosuppressive in renal transplantation? Trantsplantation 1982: 34: 268-72.","journal-title":"Trantsplantation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ard.45.3.183","article-title":"Differential effects of therapeutic regimens on specific classes of rheumatoid factor","volume":"45","author":"M, Pope R.; J, Lessard; E, Nunnery","year":"1986","unstructured":"Pope R M, Lessard J, Nunnery E. Differential effects of therapeutic regimens on specific classes of rheumatoid factor. Atnn Rheutn Dis 1986; 45: 183-9.","journal-title":"Atnn Rheutn Dis"},{"key":"ref_14","first-page":"480","article-title":"Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients","volume":"29","author":"G, Hanly J.; J, Hassan; A, Whelan; C, Feighery; B, Bresnihan","year":"1986","unstructured":"Hanly J G, Hassan J, Whelan A, Feighery C, Bresnihan B. Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients. Arthritis Rheu,n 1986; 29: 480-7."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM197804202981602","article-title":"Association of the B-cell alloantigen DRw4 with rheumatoid arthritis","volume":"298","author":"Stastny, P.","year":"1978","unstructured":"Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869-71.","journal-title":"N Engl J Med"},{"key":"ref_16","first-page":"1326","article-title":"Genetic basis of rheumatoid disease: HLA antigens, disease manifestations and toxic reactions to drugs","volume":"ii:","author":"S, Panayi G.; P, Wooley; R, Batchelor J.","year":"1978","unstructured":"Panayi G S, Wooley P, Batchelor J R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations and toxic reactions to drugs. Br Med J 1978; ii: 1326-8.","journal-title":"Br Med J"},{"key":"ref_17","first-page":"123","article-title":"Y","volume":"5","author":"Ohta, N.; Nishimura","year":"1982","unstructured":"Ohta N, Nishimura Y K, Tanimoto K, et al. Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immuniol 1982: 5: 123-32.","journal-title":"Hum Immuniol; Association between HLA and Japanese patients with rheumatoid arthritis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ard.45.3.177","article-title":"Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis","volume":"45","author":"Hakala, M.; van Assendelft A H W; Ilonen, J.; Jalava, S.; Tiilikainen, A.","year":"1986","unstructured":"Hakala M, van Assendelft A H W, Ilonen J, Jalava S, Tiilikainen A. Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis 1986; 45: 177-82.","journal-title":"Ann Rheum Dis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/ard.45.8.627","article-title":"HLA and rheumatoid arthritis: a combined analysis of 440 British patients","volume":"45","author":"Jaraquemada, D.; Ollier, W.; Awad, J.","year":"1986","unstructured":"Jaraquemada D, Ollier W, Awad J, et al. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986; 45: 627-636.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"ref_20","first-page":"138","article-title":"HL- A27 and arthritis","volume":"1975","author":"Isomaki, H.; Koota, K.; Martio, J.; Nissila, M.; Tiilikainen, A.","unstructured":"Isomaki H, Koota K, Martio J, Nissila M, Tiilikainen A. HL- A27 and arthritis. Ann Clini Res 1975: 7: 138-45.","journal-title":"Ann Clini Res"},{"key":"ref_21","first-page":"161","article-title":"Physiology and pathology of rheumatoid factors","volume":"4","author":"A, Carson D.; L, Pasquali J.; D, Tsoukas C.","year":"1981","unstructured":"Carson D A, Pasquali J L, Tsoukas C D, et al. Physiology and pathology of rheumatoid factors. Springer Semin Immunopathol 1981; 4: 161-79."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1749-6632.1983.tb18082.x","article-title":"The anti-immunoglobulins and their idiotypes: are they part of the immune network?","volume":"418","author":"G, Kunkel H.; N, Posnett D.; B, Pernis","year":"1983","unstructured":"Kunkel H G, Posnett D N, Pernis B. The anti-immunoglobulins and their idiotypes: are they part of the immune network? Ann NY Acad Sci 1983; 418: 324-9.","journal-title":"Ann NY Acad Sci"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1084\/jem.114.5.791","article-title":"The induction of a rheumatoid factor-like substance in rabbits","volume":"114","author":"L, Abruzzo J.; L, Christian C.","year":"1961","unstructured":"Abruzzo J L, Christian C L. The induction of a rheumatoid factor-like substance in rabbits. J Exp Med 1961; 114: 791-806.","journal-title":"J Exp Med"},{"key":"ref_24","first-page":"96","article-title":"Onset, early stages and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up","volume":"ii:","author":"K, Jacoby R.; V, Jayson M.I.; A, Cosh J.","year":"1973","unstructured":"Jacoby R K, Jayson M I V, Cosh J A. Onset, early stages and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. Br Med J 1973; ii: 96-100.","journal-title":"Br Med J"},{"key":"ref_25","first-page":"299","article-title":"Prospective study of the early course of rheumilatoid arthritis in youig aidults: compairison of patients with and without rheumatoid factor positivity at entry and identification of variabies correlating with outcome","volume":"5","author":"W, Masi A.T.Maldonado-Cocco J.A.Kaplan S.B.Fergenbaum S.L.Chandler R.","year":"1976","unstructured":"Masi A T. Maldonado-Cocco J A. Kaplan S B. Fergenbaum S L. Chandler R W. Prospective study of the early course of rheumilatoid arthritis in youig aidults: compairison of patients with and without rheumatoid factor positivity at entry and identification of variabies correlating with outcome. Seinin1 Arthritis Rl1elon 1976; 5: 299-326."},{"issue":"50","key":"ref_26","first-page":"28","article-title":"Association of rheumaitoid factor isotypes with fluctuations in disease activity. An1ni Rheu, n Dis 1984: 43: 679-85","volume":"1974","author":"H, Huskisson E.C.Berry","unstructured":"Association of rheumaitoid factor isotypes with fluctuations in disease activity. An1ni Rheu,n Dis 1984: 43: 679-85. 28 Huskisson E C. Berry H. Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold. Postgrad Med J 1974: 50 (suppl): 59-61.","journal-title":"Postgrad Med J; Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold"},{"key":"ref_27","first-page":"12","article-title":"Class specific rheumatoid factors in rheumatoid arthritis: responsc to chrysotherapy and relationship to disease activity","volume":"1985","author":"J, Rudge S.R.Pound J.D.Bossingham D.H.Powell R.","unstructured":"Rudge S R. Pound J D. Bossingham D H. Powell R J. Class specific rheumatoid factors in rheumatoid arthritis: responsc to chrysotherapy and relationship to disease activity. J Rhelinatol 1985: 12: 432-6.","journal-title":"J Rhelinatol"},{"issue":"1","key":"ref_28","first-page":"30","article-title":"Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine. Atnzn Rheumn Dis 1980)","volume":"1","author":"V, Dixon J.S.Pickup M.E.Lowe J.R.Hallett C.Lee M.R.Wright","unstructured":"Dixon J S. Pickup M E. Lowe J R. Hallett C. Lee M R. Wright V. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine. Atnzn Rheumn Dis 1980); 39: 30) 1-1 1."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/art.1780250503","article-title":"Seronegative rheumatoid arthritis. A distinct immunogenetic disease?","volume":"25","author":"Alarcon G S. Koopman W J, Acton R T. Barger B 0","year":"1982","unstructured":"Alarcon G S. Koopman W J, Acton R T. Barger B 0. Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthriti.s Rheumn 1982: 25: 502-7.","journal-title":"Arthriti.s Rheumn"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724117748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724117748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.47.7.546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:43:18Z","timestamp":1737524598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724117748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1988,7]]}},"alternative-id":["S0003496724117748"],"URL":"https:\/\/doi.org\/10.1136\/ard.47.7.546","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1988,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Class-specific rheumatoid factors, DR antigens, and amyloidosis in patients with rheumatoid arthritis.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.47.7.546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1988 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}